Today, on Holocaust Remembrance Day, we pause to honor the memory of the 6 million Jews murdered, and the countless others who suffered. More than 80 years later, Jewish lives are still at risk. Hostages remain in Gaza. Bring them home now. #NeverAgain #BringThemHome

📢 We’ve completed our acquisition of 71% of cultivated cacao leader Kokomodo Ltd. This step combines Pluri’s scalable cell tech with Kokomodo’s innovation to advance sustainable, climate-resilient cacao. 🍫🌱 lnkd.in/d6Rst_c2 #Pluri #Kokomodo #FoodTech #Sustainability

Today, we stand in solemn remembrance of the fallen soldiers of the IDF and the civilian victims of terror. Today, we remember. We honor. Together, we are one body. One people. One heart. #YomHaZikaron #WeRemember #Pluri #IsraelStrong #BringThemHomeNow #NeverForget

Happy 77th Independence Day, Israel! Today, we proudly celebrate 77 years of Israeli independence—a story of resilience, determination, and innovation unlike any other. #YomHaatzmaut #Israel77 #IndependenceDay #ProudlyIsraeli #InnovationNation #BringThemHomeNow #Pluri

🚀 Innovation Spotlight: we’re happy to share a new Q&A with Pluri Board Member Alejandro Weinstein, a veteran healthcare executive and investor with a deep passion for transforming science into scalable solutions. Read the full interview via Citybiz: citybiz.co/article/690836…

☕ Can coffee be climate-proof? Coffeesai, a Pluri subsidiary, is growing real coffee from plant cells—producing the equivalent of 1,000 trees in 3 weeks. The future of coffee might just be bio-farming! 🔗 lnkd.in/d-AWXudf #Coffee #FoodTech #Biotech #Sustainability

🚀 MAIT cells are making waves in immunotherapy — and we’re proud to be part of that momentum. 📖 Read more: nxtbook.com/comparenetwork… #CellTherapy #Immunotherapy #MAITCells #Biotech #Pluri

📢 Pluri CEO shares a bold vision for global growth, from cultivated cacao & coffee to 400%+ revenue growth in FY25. 🌱 Scalable biotech. Real-world impact. Read the full shareholder letter 👉 pluri-biotech.com/releases/pluri… #Biotech #FoodTech #AgTech #Pluri #Sustainability

🚀 PluriCDMO™ is your end-to-end partner for cell therapy manufacturing. With 20+ years of global experience, we support MSCs, iPSCs, immune & gene-edited cells, exosomes & more—scalable, flexible, and clinic-ready. lnkd.in/dRiPwaRB #CellTherapy #CDMO

🌟 Heading to the BIO International Convention in Boston? 🌟 Don’t miss the chance to meet Efrat Kaduri, Pluri’s Chief Business Development Officer–Pharma, at the event from June 16–19, 2025 lnkd.in/dKrXuHVa #BIO2025 #CellTherapy Biotechnology Innovation Organization

Like so many in Israel, our team at Pluri is 1navigating extremely difficult and uncertain days. In moments like these, the work we do feels even more meaningful. 1ism — imagining a better world when the present is so complex: lnkd.in/dpsztuUg #foodtech #agtech

As cell therapies move from clinical trials to commercialization, expertise becomes the biggest barrier. In his new article in Contract Pharma Pluri’s Chief Commercial Officer breaks down what biotech companies must look for in a CDMO: lnkd.in/dtXJVFgt #CDMO #Biotech

Our cells are blue and white At Pluri, innovation flows through us like it does through this country—resilient and full of hope. Because in Israel, strength isn’t just in our spirit—it’s in every cell. Wishing for quieter days, and for good news on every front. #Resilience #Hope

🌍 The world is facing a growing coffee crisis: calcalist.co.il/world_news/art…☕️ Coffeesai, our cell-based coffee platform, offers a revolutionary approach: producing real, high-quality coffee without farming, without deforestation, and without dependence on climate conditions. #Coffee

🧬 Today is Chronic Disease Day. We’re proud to be part of the PROTO consortium, a cutting-edge EU-funded collaboration focused on developing a regenerative cell therapy solution for knee osteoarthritis. 💡 Chronic diseases require chronic innovation #ChronicDiseaseDay

Pluri CSO Dr. Arthur Machlenkin shares insights in The Cancer Letter on an overlooked immune cell population that could reshape cell & gene therapy for solid tumors. Highly recommended read (subscription required): cancerletter.com/trials-and-tri… #CellTherapy #Cancer

🚀 Transforming Cell Therapy — Together Looking for a trusted partner to manufacture your cell therapy product? PluriCDMO combines 20+ years of innovation, expertise, and proprietary 3D tech to deliver end-to-end cell manufacturing solutions: lnkd.in/dRiPwaRB #biotech

After 18 amazing years, we thank Efrat Livne-Hadass for shaping Pluri’s culture with heart and vision. 💜 Welcome to Nofar Glaich-Dabach, our new VP of HR! At Pluri, cells power life—and people power progress. #biotech #HR #innovation #gratitude #leadership

As climate change drives coffee & cacao prices to record highs, Pluri is brewing a solution: lab-grown coffee. Using our cell expansion tech, we're creating sustainable, scalable alternatives—no deforestation required. 🌱☕ lnkd.in/d2DQqqqu #FoodTech #Biotech #Pluri

🇱🇹🤝🇮🇱 We were honored to host H.E. Audrius Brūzga, Ambassador of Lithuania to Israel and Commercial Attache Donata Mauricaitė, at Pluri’s headquarters. We look forward to exploring new opportunities together! #LifeSciences #Innovation #RegenerativeMedicine #Israel #Lithuania